|
Re: New patent
|
5
|
Resverlogix Corp.
|
Nov 03, 2019 11:42AM
|
|
Re: New share price contest for end of year 2019
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 11:10AM
|
|
Re: New Share Price Contest update to Oct 12th
|
6
|
Resverlogix Corp.
|
Oct 13, 2019 12:59PM
|
|
Re: News,
|
2
|
Resverlogix Corp.
|
Jun 27, 2019 05:36PM
|
|
Re: nuts!
|
4
|
Resverlogix Corp.
|
May 15, 2019 04:56PM
|
|
Re: Options
|
1
|
Resverlogix Corp.
|
Oct 22, 2019 03:36PM
|
|
Re: Other Data
|
1
|
Resverlogix Corp.
|
Sep 30, 2019 12:43PM
|
|
Re: Other Data
|
2
|
Resverlogix Corp.
|
Sep 30, 2019 01:21PM
|
|
Re: Patent Application Publication 10/31/2019 CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD. (Suzhou, Jiangsu, CN)
|
4
|
Resverlogix Corp.
|
Nov 04, 2019 10:27AM
|
|
Re: people whining about the whining
|
1
|
Resverlogix Corp.
|
Dec 23, 2020 02:39PM
|
|
Re: Presentation
|
5
|
Resverlogix Corp.
|
Sep 11, 2020 04:54PM
|
|
Re: Price trickly upwards...
|
|
Resverlogix Corp.
|
Jun 10, 2020 10:42AM
|
|
Re: Primary outcome HR= .82 (18% RRR) P=0.11
|
2
|
Resverlogix Corp.
|
Nov 16, 2019 12:08PM
|
|
Re: Question re ALP
|
1
|
Resverlogix Corp.
|
Dec 16, 2019 05:23PM
|
|
Re: Question re ALP
|
3
|
Resverlogix Corp.
|
Dec 16, 2019 10:40AM
|
|
Re: RAAS Inhibitors in Patients with Covid-19
|
1
|
Resverlogix Corp.
|
Mar 31, 2020 12:22PM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
2
|
Resverlogix Corp.
|
Jun 14, 2019 09:23AM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
1
|
Resverlogix Corp.
|
Jun 14, 2019 01:52PM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
|
Resverlogix Corp.
|
Jun 14, 2019 03:14PM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
1
|
Resverlogix Corp.
|
Jun 14, 2019 05:55PM
|
